These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 15816957
1. Hypersomnia in an epilepsy patient treated with levetiracetam. Khatami R, Siegel AM, Bassetti CL. Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957 [Abstract] [Full Text] [Related]
5. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies. Caraballo RH, Cersósimo R, De los Santos C. Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715 [Abstract] [Full Text] [Related]
6. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures. Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ. Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175 [Abstract] [Full Text] [Related]
7. The place of levetiracetam in the treatment of epilepsy. Leppik IE. Epilepsia; 2001 Mar; 42 Suppl 4():44-5. PubMed ID: 11564126 [No Abstract] [Full Text] [Related]
9. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. Szucs A, Clemens Z, Jakus R, Rásonyi G, Fabó D, Holló A, Barcs G, Kelemen A, Janszky J. Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387 [Abstract] [Full Text] [Related]
11. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome. García C, Rubio G. Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296 [Abstract] [Full Text] [Related]
13. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Piazzini A, Chifari R, Canevini MP, Turner K, Fontana SP, Canger R. Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430 [Abstract] [Full Text] [Related]
14. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Perry MS, Benatar M. Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408 [Abstract] [Full Text] [Related]
15. Status gelasticus associated with levetiracetam as add-on treatment. Pustorino G, Spano M, Sgro DL, Di Rosa G, Tricomi G, Bellantone D, Tortorella G. Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032 [Abstract] [Full Text] [Related]
17. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I. Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [Abstract] [Full Text] [Related]
18. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA). Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C. Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615 [Abstract] [Full Text] [Related]
19. Hyponatremia associated with repeated use of levetiracetam. Nasrallah K, Silver B. Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344 [Abstract] [Full Text] [Related]
20. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group. Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]